Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin.
Dul M, Alali M, Ameri M, Burke MD, Creelman BP, Dick L, Donnelly RF, Eakins MN, Frivold C, Forster AH, Gilbert PA, Henke S, Henry S, Hunt D, Lewis H, Mistilis JJ, Park JH, Prausnitz MR, Robinson DK, Hernandez CAR, Shin J, Speaker TJ, Strasinger C, Taylor KMG, Zehrung D, Birchall JC, Jarrahian C, Coulman SA. Dul M, et al. Among authors: mistilis jj. J Control Release. 2024 Dec 20;378:402-415. doi: 10.1016/j.jconrel.2024.11.056. Online ahead of print. J Control Release. 2024. PMID: 39603537 Free article.
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.
Zehrung D, Innis BL, Suwantika AA, Ameri M, Biellik R, Birchall JC, Cravioto A, Jarrahian C, Fairlie L, Goodson JL, Kochhar S, Kretsinger K, Morgan C, Mvundura M, Rathi N, Clarke E, Mistilis JJ, Uwamwezi MC, Giersing B, Hasso-Agopsowicz M. Zehrung D, et al. Among authors: mistilis jj. Vaccines (Basel). 2024 Nov 6;12(11):1258. doi: 10.3390/vaccines12111258. Vaccines (Basel). 2024. PMID: 39591161 Free PMC article.
An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries.
Ko M, Frivold C, Mvundura M, Soble A, Gregory C, Christiansen H, Hasso-Agopsowicz M, Fu H, Jit M, Hsu S, Mistilis JJ, Scarna T, Earle K, Menozzi-Arnaud M, Giersing B, Jarrahian C, Yakubu A, Malvolti S, Amorij JP. Ko M, et al. Among authors: mistilis jj. Vaccines (Basel). 2024 Sep 19;12(9):1075. doi: 10.3390/vaccines12091075. Vaccines (Basel). 2024. PMID: 39340105 Free PMC article.
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Dul M, Alali M, Ameri M, Burke MD, Craig CM, Creelman BP, Dick L, Donnelly RF, Eakins MN, Frivold C, Forster AH, Gilbert PA, Henke S, Henry S, Hunt D, Lewis H, Maibach HI, Mistilis JJ, Park JH, Prausnitz MR, Robinson DK, Hernandez CAR, Ross C, Shin J, Speaker TJ, Taylor KM, Zehrung D, Birchall JC, Jarrahian C, Coulman SA. Dul M, et al. Among authors: mistilis jj. J Control Release. 2023 Sep;361:236-245. doi: 10.1016/j.jconrel.2023.07.001. Epub 2023 Aug 8. J Control Release. 2023. PMID: 37437849 Free article.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Scarnà T, Menozzi-Arnaud M, Friede M, DeMarco K, Plopper G, Hamer M, Chakrabarti A, Gilbert PA, Jarrahian C, Mistilis J, Hesselink R, Gandrup-Marino K, Amorij JP, Giersing B. Scarnà T, et al. Among authors: mistilis j. Expert Opin Drug Deliv. 2023 Mar;20(3):315-322. doi: 10.1080/17425247.2023.2168641. Epub 2023 Jan 27. Expert Opin Drug Deliv. 2023. PMID: 36649573 Free article.
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Kinvig H, Cottura N, Lloyd A, Frivold C, Mistilis J, Jarrahian C, Siccardi M. Kinvig H, et al. Among authors: mistilis j. Eur J Drug Metab Pharmacokinet. 2023 Jan;48(1):119. doi: 10.1007/s13318-022-00811-7. Eur J Drug Metab Pharmacokinet. 2023. PMID: 36517732 Free PMC article. No abstract available.
Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.
Moffatt K, Tekko IA, Vora L, Volpe-Zanutto F, Hutton ARJ, Mistilis J, Jarrahian C, Akhavein N, Weber AD, McCarthy HO, Donnelly RF. Moffatt K, et al. Among authors: mistilis j. Pharm Res. 2023 Jul;40(7):1673-1696. doi: 10.1007/s11095-022-03408-6. Epub 2022 Oct 12. Pharm Res. 2023. PMID: 36224503 Free PMC article.
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Kinvig H, Cottura N, Lloyd A, Frivold C, Mistilis J, Jarrahian C, Siccardi M. Kinvig H, et al. Among authors: mistilis j. Eur J Drug Metab Pharmacokinet. 2022 Nov;47(6):855-868. doi: 10.1007/s13318-022-00793-6. Epub 2022 Sep 30. Eur J Drug Metab Pharmacokinet. 2022. PMID: 36178586 Free PMC article.
11 results